Clearside Biomedical Inc (CLSD)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
Clearside Biomedical Total Return Level: 1.31 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 1.31 |
May 02, 2024 | 1.32 |
May 01, 2024 | 1.27 |
April 30, 2024 | 1.26 |
April 29, 2024 | 1.29 |
April 26, 2024 | 1.34 |
April 25, 2024 | 1.26 |
April 24, 2024 | 1.34 |
April 23, 2024 | 1.37 |
April 22, 2024 | 1.41 |
April 19, 2024 | 1.31 |
April 18, 2024 | 1.32 |
April 17, 2024 | 1.26 |
April 16, 2024 | 1.15 |
April 15, 2024 | 1.29 |
April 12, 2024 | 1.25 |
April 11, 2024 | 1.30 |
April 10, 2024 | 1.24 |
April 09, 2024 | 1.29 |
April 08, 2024 | 1.29 |
April 05, 2024 | 1.30 |
April 04, 2024 | 1.33 |
April 03, 2024 | 1.43 |
April 02, 2024 | 1.40 |
April 01, 2024 | 1.58 |
Date | Value |
---|---|
March 28, 2024 | 1.53 |
March 27, 2024 | 1.67 |
March 26, 2024 | 1.69 |
March 25, 2024 | 1.73 |
March 22, 2024 | 1.71 |
March 21, 2024 | 1.80 |
March 20, 2024 | 1.63 |
March 19, 2024 | 1.63 |
March 18, 2024 | 1.56 |
March 15, 2024 | 1.71 |
March 14, 2024 | 1.73 |
March 13, 2024 | 1.63 |
March 12, 2024 | 1.64 |
March 11, 2024 | 2.02 |
March 08, 2024 | 1.67 |
March 07, 2024 | 1.67 |
March 06, 2024 | 1.51 |
March 05, 2024 | 1.39 |
March 04, 2024 | 1.39 |
March 01, 2024 | 1.39 |
February 29, 2024 | 1.40 |
February 28, 2024 | 1.41 |
February 27, 2024 | 1.395 |
February 26, 2024 | 1.34 |
February 23, 2024 | 1.36 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.5858
Minimum
Sep 03 2019
7.20
Maximum
Aug 27 2021
2.012
Average
1.51
Median
Feb 22 2022
Total Return Level Benchmarks
Cassava Sciences Inc | 37.28 |
Heron Therapeutics Inc | 2.61 |
Actinium Pharmaceuticals Inc | 8.96 |
Karyopharm Therapeutics Inc | 1.13 |
Ocular Therapeutix Inc | 6.17 |